![Catherine Park](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Catherine Park
Geen lopende functies
Profiel
Catherine Park is the founder of OncoSynergy, Inc. which was founded in 2011.
Eerdere bekende functies van Catherine Park
Bedrijven | Functie | Einde |
---|---|---|
OncoSynergy, Inc.
![]() OncoSynergy, Inc. Pharmaceuticals: MajorHealth Technology OncoSynergy, Inc. engages in the provision of solutions for treatment-resistant cancer. It develops new class of oncology therapeutics, called Resistance Mechanism Inhibitors (RMIs), it is a multi-action, tumor-agnostic drug platforms that have shown preclinical promise as monotherapy and in strategic combinations. The company was founded by Shawn W. Carbonell, Anne-Marie Carbonell, and Catherine Park in 2011 and is headquartered in Greenwich, CT. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
OncoSynergy, Inc.
![]() OncoSynergy, Inc. Pharmaceuticals: MajorHealth Technology OncoSynergy, Inc. engages in the provision of solutions for treatment-resistant cancer. It develops new class of oncology therapeutics, called Resistance Mechanism Inhibitors (RMIs), it is a multi-action, tumor-agnostic drug platforms that have shown preclinical promise as monotherapy and in strategic combinations. The company was founded by Shawn W. Carbonell, Anne-Marie Carbonell, and Catherine Park in 2011 and is headquartered in Greenwich, CT. | Health Technology |